Medicare Enrolled

Dr. Sandeep Thaper, M.D.

Hematology · Leesburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
601 E DIXIE AVE STE 1001, Leesburg, FL 34748
3527879448
In practice since 2006 (19 years)
NPI: 1881627966 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Thaper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thaper? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Thaper

Dr. Sandeep Thaper is a hematology in Leesburg, FL, with 19 years in practice. Based on federal Medicare data, Dr. Thaper performed 253,844 Medicare services across 5,988 unique beneficiaries.

Between the years covered by Open Payments, Dr. Thaper received a total of $20,919 from 90 pharmaceutical and/or device companies across 1122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Thaper is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 12% volume in FL$ $20,919 industry payments

Medicare Practice Summary

Medicare Utilization ↗
253,844
Medicare services
Top 12% in FL for hematology
5,988
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13,360 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)67,700$0$5
Filgrastim injection (Zarxio) for white blood cells47,040$0$2
Pembrolizumab injection (Keytruda)31,200$43$137
Paclitaxel chemotherapy injection17,783$0$2
Denosumab injection (Prolia/Xgeva)17,400$18$51
Iron infusion (Feraheme)15,810$0$4
Epoetin alfa injection (Procrit) for anemia11,270$6$23
Anti-nausea injection (aprepitant)10,790$1$5
Immune globulin infusion (Gammagard)7,446$36$108
Complete blood count (CBC) with differential3,880$8$29
Blood draw (venipuncture)3,674$8$9
Dexamethasone injection (steroid)3,132$0$3
Drug injection, under skin or into muscle2,499$10$69
Office visit, established patient (20-29 min)2,455$66$239
Anti-nausea injection (Aloxi/palonosetron)1,730$1$28
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg1,693$1$6
Iron infusion (Monoferric)1,400$17$57
Anti-nausea injection (ondansetron/Zofran)1,388$0$9
Injection of additional new drug or substance into vein778$11$61
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less599$46$189
Injection, fluorouracil, 500 mg567$2$7
Administration of chemotherapy into vein, 1 hour or less518$96$378
Injection, carboplatin, 50 mg395$2$41
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour319$15$56
Injection, diphenhydramine hcl, up to 50 mg241$1$3
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional177$17$59
Initial hospital admission, moderate complexity156$103$377
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle147$25$89
Injection of drug or substance into vein146$27$156
Administration of chemotherapy into vein, each additional hour140$21$79
Prothrombin time test (blood clotting)138$4$15
Administration of additional new drug or substance into vein, 1 hour or less121$49$178
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less112$21$84
New patient office visit (30-44 min)104$81$298
Hospital follow-up visit, moderate complexity104$63$197
Telephone medical discussion with physician, 5-10 minutes90$40$115
Office visit, established patient (30-39 min)84$96$339
Office visit, established patient (10-19 min)78$42$147
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle69$54$206
Infusion into a vein for hydration, each additional hour62$10$42
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l59$127$637
Infusion, normal saline solution, sterile (500 ml = 1 unit)53$1$7
Administration of additional new drug or substance into vein using push technique45$42$170
Infusion into a vein for hydration, 31-60 minutes44$24$156
Infusion, normal saline solution , 1000 cc44$2$7
Drawing of blood for a medical problem35$64$277
Red blood count automated, with additional calculations32$5$20
Injection, methylprednisolone sodium succinate, up to 40 mg31$3$11
Red blood count, automated test23$4$10
New patient office visit (45-59 min)23$122$453
Biopsy and aspiration of bone marrow sample for diagnosis20$130$467
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.2% high complexity
85.4% medium
4.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$20,919
Total received (2018-2024)
Avg $2,988/year across 7 years
Top 22% in FL for hematology
90
Companies
1,122
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,492 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$427 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,962
2023
$3,019
2022
$2,931
2021
$2,838
2020
$2,330
2019
$3,328
2018
$2,511

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,596
E.R. Squibb & Sons, L.L.C.
$1,459
Janssen Biotech, Inc.
$1,408
Celgene Corporation
$1,024
GENZYME CORPORATION
$954
Merck Sharp & Dohme Corporation
$890
Incyte Corporation
$827
PFIZER INC.
$817
AstraZeneca Pharmaceuticals LP
$762
Genentech USA, Inc.
$743
Amgen Inc.
$741
Seagen Inc.
$633
Merck Sharp & Dohme LLC
$526
Lilly USA, LLC
$519
Astellas Pharma US Inc
$510
GlaxoSmithKline, LLC.
$458
Daiichi Sankyo Inc.
$419
EMD Serono, Inc.
$408
Eisai Inc.
$331
Pharmacyclics LLC, An AbbVie Company
$319
Gilead Sciences, Inc.
$301
Kite Pharma, Inc.
$300
Foundation Medicine, Inc.
$285
Bayer HealthCare Pharmaceuticals Inc.
$227
Alexion Pharmaceuticals, Inc.
$225
ABBVIE INC.
$203
Regeneron Healthcare Solutions, Inc.
$201
ARRAY BIOPHARMA INC
$194
Boehringer Ingelheim Pharmaceuticals, Inc.
$183
BeiGene USA, Inc.
$179
Octapharma USA, Inc.
$177
Takeda Pharmaceuticals U.S.A., Inc.
$168
Agios Pharmaceuticals, Inc.
$157
Bayer Healthcare Pharmaceuticals Inc.
$131
JAZZ PHARMACEUTICALS INC.
$123
Pharmacyclics LLC, an AbbVie Company
$122
Spectrum Pharmaceuticals Inc.
$120
Dova Pharmaceuticals
$119
MorphoSys, US Inc.
$118
EISAI INC.
$115
Tempus AI, Inc
$110
Teva Pharmaceuticals USA, Inc.
$89
Stemline Therapeutics Inc.
$85
Seattle Genetics, Inc.
$83
Aurobindo Pharma USA, Inc.
$75
Genmab U.S., Inc.
$71
Mirati Therapeutics, Inc.
$66
Pharmacosmos Therapeutics Inc.
$63
Clovis Oncology, Inc.
$59
TerSera Therapeutics LLC
$59
TG THERAPEUTICS, INC.
$57
Ipsen Biopharmaceuticals, Inc
$51
Apellis Pharmaceuticals, Inc.
$49
Adaptive Biotechnologies Corporation
$47
SOBI, INC
$44
ADC Therapeutics America, Inc.
$43
AbbVie Inc.
$42
Secura Bio, Inc.
$41
TAIHO ONCOLOGY, INC.
$40
SERVIER PHARMACEUTICALS LLC
$40
Rigel Pharmaceuticals, Inc.
$37
G1 Therapeutics, Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$35
AVEO Pharmaceuticals, Inc.
$35
Karyopharm Therapeutics Inc.
$35
Global Blood Therapeutics, Inc.
$33
INSYS Therapeutics Inc
$33
Exelixis Inc.
$31
Array BioPharma Inc.
$31
Epizyme, Inc.,
$30
Jazz Pharmaceuticals Inc.
$30
TESARO, Inc.
$29
Verastem, Inc.
$29
Servier Pharmaceuticals LLC
$28
GE HEALTHCARE
$27
PharmaEssentia USA Corporation
$25
Puma Biotechnology, Inc.
$23
Tolmar, Inc.
$23
Telix Pharmaceuticals
$23
SANOFI-AVENTIS U.S. LLC
$21
Lexicon Pharmaceuticals, Inc.
$18
Taiho Oncology, Inc.
$17
MEDIVATION FIELD SOLUTIONS LLC
$14
CTI BioPharma Corp.
$14
Kyowa Kirin, Inc.
$14
Myriad Genetic Laboratories, Inc.
$13
Heron Therapeutics, Inc.
$13
NanoString Technologies, Inc.
$12
Janssen Pharmaceuticals, Inc
$3
Veracyte, Inc.
$2
Top 3 companies account for 21.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CALQUENCE · CARVYKTI · CERDELGA · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · EVENITY · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gazyva · IBRANCE · ICLUSIG · IDHIFA · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROSTATE CANCER - DISEASE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAXOTERE · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $8 per 100 Medicare services performed
Looking for a hematology in Leesburg?
Compare hematologys in the Leesburg area by procedure volume, costs, and industry payment transparency.
Browse hematologys nearby

Geographic Context

Hematologys within 10 mi
8
Per 100K population
2.0
County median income
$69,956
Nearest hospital
UF HEALTH LEESBURG HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Thaper is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Thaper experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Thaper performed 67,700 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Thaper receive payments from pharmaceutical companies?
Yes. Dr. Thaper received a total of $20,919 from 90 companies across 1,122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thaper's costs compare to other hematologys in Leesburg?
Dr. Thaper's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thaper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →